KARA AUSTIN: Open Payments
NPI 1003477449 · GREENWOOD, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$592 in 21 payments from 8 companies in 2025. Trend: 2023 $123 · 2024 $472 · 2025 $592
Food & beverage: $592
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 5 | $205 |
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $137 |
| Ardelyx, Inc. | 5 | $82 |
| Bard Peripheral Vascular, Inc. | 1 | $78 |
| Travere Therapeutics, Inc. | 1 | $32 |
| Boston Scientific Corporation | 1 | $21 |
| Calliditas Therapeutics US Inc. | 1 | $20 |
| Fresenius USA Marketing, Inc. | 1 | $17 |
Products named: Vanrafia, Kerendia, IBSRELA, RotarexS 6 F x 135 cm, Fabhalta, FARAPULSE, TARPEYO, VELPHORO.
Industry payments across MS — which companies pay providers there.
